Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ronda Henry-Tillman

Concepts (256)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
39
2024
1203
4.530
Why?
Early Detection of Cancer
6
2020
185
2.200
Why?
Ultrasonography, Mammary
8
2020
61
1.920
Why?
Mass Screening
3
2020
354
1.430
Why?
Colorectal Neoplasms
4
2018
286
1.400
Why?
Healthcare Disparities
3
2017
291
1.030
Why?
Mastectomy
13
2019
145
1.020
Why?
Mastectomy, Segmental
7
2018
94
1.000
Why?
Sentinel Lymph Node Biopsy
10
2015
119
0.950
Why?
Community Health Planning
3
2018
29
0.930
Why?
Ultrasonography, Interventional
5
2020
137
0.790
Why?
Biopsy, Needle
10
2015
181
0.790
Why?
Focus Groups
1
2024
201
0.780
Why?
Neoplasm Staging
14
2024
768
0.770
Why?
Biopsy, Large-Core Needle
3
2020
33
0.760
Why?
Female
55
2024
28277
0.720
Why?
Genetic Counseling
1
2022
44
0.710
Why?
Lymph Nodes
7
2015
253
0.710
Why?
Neoplasms
5
2015
1314
0.700
Why?
Health Status Disparities
3
2015
218
0.690
Why?
Patient Education as Topic
1
2024
317
0.680
Why?
Image Interpretation, Computer-Assisted
1
2020
96
0.650
Why?
Image-Guided Biopsy
2
2020
35
0.620
Why?
Middle Aged
40
2024
13133
0.610
Why?
Hematoma
4
2018
67
0.600
Why?
Surgery, Computer-Assisted
2
2018
54
0.600
Why?
Polymorphism, Single Nucleotide
2
2018
506
0.580
Why?
Humans
60
2024
52441
0.580
Why?
Mandatory Programs
1
2018
22
0.560
Why?
Adiposity
1
2019
147
0.540
Why?
Faculty, Medical
3
2021
92
0.540
Why?
Health Care Costs
1
2018
176
0.530
Why?
Adult
32
2024
14205
0.520
Why?
Aged
31
2024
10242
0.520
Why?
Insurance Coverage
1
2018
106
0.520
Why?
Disease Management
1
2018
185
0.500
Why?
Diagnostic Imaging
1
2018
171
0.500
Why?
Minority Groups
3
2015
136
0.480
Why?
Arkansas
9
2018
2013
0.470
Why?
Physicians
1
2018
237
0.440
Why?
Retrospective Studies
19
2022
6694
0.440
Why?
Health Planning Councils
1
2014
6
0.430
Why?
Community-Based Participatory Research
2
2015
202
0.410
Why?
Rural Population
1
2017
587
0.390
Why?
Health Policy
1
2014
162
0.390
Why?
Follow-Up Studies
11
2018
2294
0.380
Why?
Aged, 80 and over
14
2018
3449
0.370
Why?
Qualitative Research
3
2024
365
0.370
Why?
Community Networks
2
2015
51
0.360
Why?
Community-Institutional Relations
1
2011
48
0.360
Why?
Primary Health Care
2
2024
387
0.360
Why?
Carcinoma, Ductal, Breast
4
2015
89
0.350
Why?
Carcinoma, Lobular
2
2015
32
0.350
Why?
Population Surveillance
1
2012
167
0.340
Why?
Physicians, Women
2
2021
21
0.330
Why?
Neoplasm Recurrence, Local
6
2014
639
0.320
Why?
Women's Health
1
2010
87
0.310
Why?
Health Education
2
2008
157
0.310
Why?
Needs Assessment
2
2024
141
0.310
Why?
Medical Oncology
1
2010
97
0.300
Why?
Breast Diseases
4
2018
25
0.290
Why?
Schools, Medical
2
2020
68
0.270
Why?
Nipples
5
2013
33
0.270
Why?
Health Knowledge, Attitudes, Practice
1
2012
504
0.270
Why?
Axilla
6
2015
92
0.270
Why?
Socioeconomic Factors
3
2018
609
0.270
Why?
Morbidity
2
2018
137
0.270
Why?
Physician-Patient Relations
2
2012
142
0.250
Why?
Health Services Accessibility
1
2011
444
0.250
Why?
Catheter Ablation
4
2014
125
0.240
Why?
Mammaplasty
3
2013
43
0.240
Why?
Lymphatic Metastasis
7
2015
210
0.240
Why?
Mentors
1
2006
55
0.230
Why?
Prognosis
9
2024
2100
0.230
Why?
Survivors
2
2024
121
0.230
Why?
Occult Blood
2
2017
23
0.230
Why?
United States
7
2022
5215
0.220
Why?
Magnetic Resonance Imaging
5
2014
1507
0.220
Why?
Young Adult
5
2024
4346
0.210
Why?
Referral and Consultation
2
2024
288
0.200
Why?
Education, Medical, Graduate
2
2022
217
0.200
Why?
Technetium Tc 99m Sulfur Colloid
4
2008
31
0.190
Why?
Male
13
2022
26874
0.190
Why?
Empathy
1
2002
47
0.180
Why?
Problem-Based Learning
1
2002
49
0.180
Why?
Emotions
1
2023
172
0.180
Why?
Atrial Fibrillation
1
2024
196
0.180
Why?
Breast
2
2020
86
0.170
Why?
Democratic Republic of the Congo
1
2020
4
0.170
Why?
Genetic Testing
1
2022
130
0.170
Why?
Counseling
1
2022
133
0.170
Why?
Dermatologic Surgical Procedures
3
2013
35
0.170
Why?
Combined Modality Therapy
4
2018
641
0.170
Why?
Feasibility Studies
2
2020
404
0.170
Why?
Biopsy, Fine-Needle
1
2020
104
0.160
Why?
Research Support as Topic
1
2020
44
0.160
Why?
Students, Medical
1
2002
157
0.160
Why?
General Surgery
1
2021
106
0.160
Why?
Surgical Flaps
2
2019
111
0.150
Why?
Obesity
1
2008
1176
0.150
Why?
Prospective Studies
10
2024
2433
0.150
Why?
Incidence
2
2024
1096
0.150
Why?
Patient Satisfaction
2
2019
287
0.150
Why?
Radiopharmaceuticals
4
2008
198
0.140
Why?
Diagnosis, Differential
1
2020
1028
0.130
Why?
Adipose Tissue
1
2019
205
0.130
Why?
Logistic Models
2
2018
930
0.130
Why?
Lymphatic Vessels
2
2008
38
0.130
Why?
Rural Health
1
2017
85
0.130
Why?
Odds Ratio
1
2018
563
0.130
Why?
Internship and Residency
1
2022
438
0.130
Why?
Zambia
3
2024
3
0.120
Why?
Mammography
1
2016
97
0.120
Why?
Rural Health Services
1
2018
177
0.120
Why?
Cytodiagnosis
2
2013
42
0.120
Why?
Genetic Predisposition to Disease
1
2018
525
0.120
Why?
Case-Control Studies
1
2018
1202
0.110
Why?
Cross-Sectional Studies
3
2021
1677
0.110
Why?
Risk Assessment
2
2018
1349
0.110
Why?
National Cancer Institute (U.S.)
1
2015
33
0.110
Why?
Survival Rate
1
2017
944
0.110
Why?
Uterine Cervical Neoplasms
1
2017
299
0.110
Why?
Algorithms
1
2018
673
0.110
Why?
Career Mobility
2
2021
29
0.100
Why?
Patient Care Planning
1
2013
68
0.100
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2013
47
0.100
Why?
Monitoring, Intraoperative
3
2014
52
0.100
Why?
Education, Medical
2
2006
112
0.100
Why?
Sigmoidoscopy
1
2012
10
0.090
Why?
Reagent Kits, Diagnostic
1
2012
17
0.090
Why?
Health Services
1
2012
66
0.090
Why?
Lymph Node Excision
4
2008
133
0.090
Why?
Reproducibility of Results
1
2015
1223
0.090
Why?
Colonoscopy
1
2012
105
0.090
Why?
Treatment Outcome
9
2017
5508
0.090
Why?
Receptors, Estrogen
2
2015
133
0.090
Why?
Pancreatic Neoplasms
1
2013
208
0.090
Why?
Feces
1
2012
159
0.090
Why?
Lymphedema
2
2008
47
0.080
Why?
Clinical Competence
1
2013
405
0.080
Why?
Fructose
1
2010
21
0.080
Why?
Patient Compliance
1
2012
228
0.080
Why?
Carbon
1
2010
60
0.080
Why?
Registries
1
2013
638
0.080
Why?
History, 21st Century
1
2010
60
0.080
Why?
Risk Factors
3
2024
3971
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1020
0.070
Why?
Carcinoma in Situ
2
2006
72
0.070
Why?
Patient Acceptance of Health Care
1
2012
351
0.070
Why?
Delivery of Health Care
1
2011
317
0.070
Why?
Models, Theoretical
2
2006
181
0.070
Why?
Prochlorperazine
1
2006
6
0.060
Why?
Postoperative Nausea and Vomiting
1
2006
20
0.060
Why?
Sensitivity and Specificity
3
2004
871
0.060
Why?
Antiemetics
1
2006
32
0.060
Why?
Education, Medical, Continuing
1
2006
76
0.060
Why?
Receptor, erbB-2
1
2006
79
0.060
Why?
Body Weights and Measures
1
2005
18
0.060
Why?
Biopsy
2
2004
594
0.060
Why?
Predictive Value of Tests
2
2013
938
0.060
Why?
Intraoperative Care
2
2003
51
0.060
Why?
Gadolinium
1
2005
44
0.060
Why?
Interprofessional Relations
1
2006
91
0.060
Why?
Tissue Expansion Devices
1
2004
3
0.060
Why?
Neoadjuvant Therapy
2
2017
124
0.060
Why?
Neuromuscular Agents
1
2004
8
0.060
Why?
Imaging, Three-Dimensional
1
2005
150
0.060
Why?
Botulinum Toxins, Type A
1
2004
14
0.060
Why?
Contrast Media
1
2005
173
0.050
Why?
Life Expectancy
1
2024
34
0.050
Why?
Cytological Techniques
1
2003
13
0.050
Why?
Anthracyclines
1
2024
34
0.050
Why?
Neoplasms, Multiple Primary
1
2003
44
0.050
Why?
Neoplasm Grading
2
2014
127
0.050
Why?
Pain, Postoperative
1
2004
169
0.050
Why?
Preoperative Care
3
2014
173
0.050
Why?
Surgical Instruments
1
2002
29
0.050
Why?
Foreign-Body Migration
1
2002
30
0.050
Why?
Humanism
1
2002
8
0.050
Why?
Life Change Events
1
2002
35
0.050
Why?
Confidence Intervals
1
2002
158
0.050
Why?
Program Development
1
2002
164
0.040
Why?
Career Choice
1
2002
117
0.040
Why?
Sexism
1
2021
11
0.040
Why?
Image Processing, Computer-Assisted
1
2002
234
0.040
Why?
Leadership
1
2021
105
0.040
Why?
Neoplasm Invasiveness
2
2010
278
0.040
Why?
Vacuum
2
2011
11
0.040
Why?
Curriculum
1
2002
406
0.040
Why?
Stereotaxic Techniques
2
2010
41
0.040
Why?
Angiopoietin-2
1
2017
14
0.030
Why?
Angiopoietin-1
1
2017
16
0.030
Why?
Receptor, TIE-2
1
2017
16
0.030
Why?
Fibroblast Growth Factor 2
1
2017
35
0.030
Why?
Clinical Trials, Phase II as Topic
1
2017
48
0.030
Why?
Gene Frequency
1
2017
97
0.030
Why?
Injections, Intralesional
2
2008
32
0.030
Why?
Matrix Metalloproteinase 9
1
2017
88
0.030
Why?
Adolescent
3
2013
6713
0.030
Why?
Vascular Endothelial Growth Factor A
1
2017
186
0.030
Why?
Guidelines as Topic
1
2016
111
0.030
Why?
Neovascularization, Pathologic
1
2017
158
0.030
Why?
Regression Analysis
1
2017
400
0.030
Why?
Coloring Agents
2
2007
68
0.030
Why?
Radionuclide Imaging
2
2007
101
0.030
Why?
Educational Status
1
2016
227
0.030
Why?
Genotype
1
2017
563
0.030
Why?
Taxoids
1
2015
38
0.030
Why?
Receptors, Progesterone
1
2015
68
0.030
Why?
Cohort Studies
2
2011
1576
0.030
Why?
Cyclophosphamide
1
2015
176
0.030
Why?
Touch
1
2013
25
0.030
Why?
Ultrasonography, Doppler
1
2014
42
0.030
Why?
Carcinoma
1
2015
135
0.030
Why?
Angiogenesis Inhibitors
1
2015
183
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2015
230
0.020
Why?
Disease-Free Survival
1
2014
461
0.020
Why?
Kaplan-Meier Estimate
1
2014
485
0.020
Why?
Cicatrix
1
2011
42
0.020
Why?
Microscopy, Phase-Contrast
1
2010
9
0.020
Why?
Plant Lectins
1
2010
8
0.020
Why?
Glycosylation
1
2010
104
0.020
Why?
Substrate Specificity
1
2010
197
0.020
Why?
Actins
1
2010
112
0.020
Why?
Tumor Cells, Cultured
1
2010
441
0.020
Why?
Cell Movement
1
2010
271
0.020
Why?
Breast Neoplasms, Male
1
2009
6
0.020
Why?
Pilot Projects
1
2011
725
0.020
Why?
Arm
1
2008
46
0.020
Why?
Phenotype
1
2010
792
0.020
Why?
Cost-Benefit Analysis
1
2008
271
0.020
Why?
Positron-Emission Tomography
1
2008
297
0.020
Why?
Administration, Rectal
1
2006
8
0.020
Why?
Cell Line, Tumor
1
2010
1429
0.020
Why?
Primary Prevention
1
2006
46
0.020
Why?
Probability
1
2006
171
0.020
Why?
Drug Administration Schedule
1
2006
370
0.010
Why?
Carcinoma, Ductal
1
2004
7
0.010
Why?
Administration, Oral
1
2006
455
0.010
Why?
Tissue Expansion
1
2004
4
0.010
Why?
Pectoralis Muscles
1
2004
6
0.010
Why?
Rectus Abdominis
1
2004
10
0.010
Why?
Spasm
1
2004
9
0.010
Why?
Multivariate Analysis
1
2006
601
0.010
Why?
Laser Coagulation
1
2004
26
0.010
Why?
Cryosurgery
1
2004
36
0.010
Why?
Sampling Studies
1
2004
38
0.010
Why?
Statistics, Nonparametric
1
2004
199
0.010
Why?
Chi-Square Distribution
1
2004
292
0.010
Why?
Injections
1
2003
60
0.010
Why?
Pain Measurement
1
2004
263
0.010
Why?
Dose-Response Relationship, Drug
1
2006
1365
0.010
Why?
Ultrasonography
1
2004
416
0.010
Why?
Length of Stay
1
2004
673
0.010
Why?
Reoperation
1
2002
463
0.010
Why?
Analgesics, Opioid
1
2004
601
0.010
Why?
Henry-Tillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description